Annual accounts
Total Exemption Full accounts
30/04/2026Filing deadline
Made up to 31/07/2024Due 30/04/2026
- Next accounts made up to
- 31/07/2025
- Last accounts made up to
- 31/07/2024
ANTIKOR BIOPHARMA LIMITED
Active- 04170519Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 80 Cheapside, London EC2V 6EE
- Classification (SIC)
- Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 15/07/2026View PDF (1 pages)
Previous accounting period shortened from 2026-07-31 to 2025-12-31
- 26/06/2026View PDF (1 pages)
Registered office address changed from Montague House Chancery Lane Thrapston Northamptonshire NN14 4LN to 80 Cheapside London EC2V 6EE on 2026-06-26
- 22/06/2026View PDF (4 pages)
Confirmation statement made on 2026-06-12 with updates
- 21/04/2026View PDF (12 pages)
Total exemption full accounts made up to 2025-07-31
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
148 days overdue
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 01/03/2026
- Last statement dated
- 31/07/2024
Financial performance
The latest figures ANTIKOR BIOPHARMA LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£9.20M2025
4.36%vs 20242024: £8.81M
Total Assets
£430.75K2025
0.38%vs 20242024: £429.11K
Cash in Bank
£108.89K2025
423.56%vs 20242024: £20.80K
Total Liabilities
£4.46M2025
20.51%vs 20242024: £3.70M
Employees
02025
0vs 20242024: 0
Of the 4 measures with an earlier filing to compare against, 4 rose. Total liabilities moved furthest, up 20.51% on 2024. See the full financial analysis for ANTIKOR BIOPHARMA LIMITED.
The full financial record
Four ways through ANTIKOR BIOPHARMA LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +5.2% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 0 | 0 |
| 2024 | 0 | -13 |
| 2023 | 13 | +2 |
| 2022 | 11 | -1 |
| 2021 | 12 | – |
Reported employee count decreased from 12 in 2021 to 0 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
18Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Nominee Secretary | 01/03/2001–04/04/2001 | 99601 | |
| Nominee Director | 01/03/2001–04/04/2001 | 43699 | |
| Director | 01/01/2008–22/07/2019 | 3 | |
| Director | 01/10/2011–23/07/2019 | 3 | |
| Director | 16/09/2005–Present | 4 | |
| Director | 01/08/2004–03/08/2016 | 4 | |
| Director | 30/04/2001–16/09/2005 | 2 | |
| Director | 01/01/2008–10/06/2015 | 3 | |
| Secretary | 30/11/2007–18/09/2009 | 5 | |
| Secretary | 04/04/2001–30/11/2007 | 46 | |
| Director | 30/04/2001–27/06/2025 | 8 | |
| Director | 30/04/2001–01/01/2008 | 3 | |
| Corporate Secretary | 18/09/2009–15/12/2025 | 11 | |
| Director | 04/04/2001–27/04/2001 | 0 | |
| Director | 21/01/2019–Present | 0 | |
| Director | 04/06/2001–01/01/2008 | 3 | |
| Director | 13/05/2023–Present | 0 | |
| Director | 30/06/2025–Present | 0 |
Persons with significant control
5Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 06/04/2016–24/07/2019 | 0 | |
| 24/07/2019–03/10/2025 | 0 | |
| 24/07/2019–Present | 0 | |
| 15/12/2025–Present | 0 | |
| 15/12/2025–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 160 Since 01/03/2001
- Last 12 months
- 10 +2 vs the year before
- Most recent filing
- 15/07/2026 2 months ago
What changed in the last year
- Registered officeLatest 26/06/2026
- Confirmation statementLatest 22/06/2026
- Accounts filedLatest 21/04/2026
- Officer changes (4)Latest 05/03/2026
Filing timeline
- 15/07/2026View PDF (1 pages)
Previous accounting period shortened from 2026-07-31 to 2025-12-31
- 26/06/2026View PDF (1 pages)
Registered office address changed from Montague House Chancery Lane Thrapston Northamptonshire NN14 4LN to 80 Cheapside London EC2V 6EE on 2026-06-26
- 22/06/2026View PDF (4 pages)
Confirmation statement made on 2026-06-12 with updates
- 21/04/2026View PDF (12 pages)
Total exemption full accounts made up to 2025-07-31
- 05/03/2026View PDF (2 pages)
Notification of Hian Leng Malcolm Ngiam as a person with significant control on 2025-12-15
- 05/03/2026View PDF (2 pages)
Notification of Mia Je Patrick Ngiam as a person with significant control on 2025-12-15
- 12/01/2026View PDF (20 pages)
Memorandum and Articles of Association
- 12/01/2026View PDF (1 pages)
Resolutions
- 15/12/2025View PDF (1 pages)
Termination of appointment of Vincent Sykes & Higham Llp as a secretary on 2025-12-15
- 12/12/2025View PDF (1 pages)
Cessation of George Albert Brown as a person with significant control on 2025-10-03
- 26/08/2025View PDF (3 pages)
Statement of capital following an allotment of shares on 2025-08-15
- 30/07/2025View PDF (16 pages)
Memorandum and Articles of Association
Showing 12 of 160 filings
See when the next accounts and confirmation statement are due
Similar companies
69 UK companies are similar to ANTIKOR BIOPHARMA LIMITED, sharing the same company status (Active), the same industry sector and activity group (Other research and experimental development on natural sciences and engineering) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
PEPTCELL LIMITED
Active4th Floor, Silverstream House,, 45 Fitzroy Street, London W1T 6EB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 04983543
- Incorporated
- 03/12/2003
- Employees
- 0
I-BODI LTD
ActiveUnit 8 Swan Business Centre, Osier Way, Buckingham, Buckinghamshire MK18 1TB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 05572182
- Incorporated
- 23/09/2005
- Employees
- 0
LEVITY CROPSCIENCE LIMITED
ActiveCrowhall Farm Newsham Hall Lane, Woodplumpton, Preston PR4 0AS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 07125879
- Incorporated
- 14/01/2010
- Employees
- 0
LIG NANOWISE LIMITED
ActiveUnit 18, Williams House Lloyd Street North, Manchester Science Park, Manchester M15 6SE
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08835324
- Incorporated
- 07/01/2014
- Employees
- 0
LIG TECHNOLOGIES LIMITED
ActiveApartment 13 Queens College Chambers, 38 Paradise Street, Birmingham B1 2AF
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08827993
- Incorporated
- 31/12/2013
- Employees
- 0
About ANTIKOR BIOPHARMA LIMITED
A short description of the company, written from its Companies House record.
ANTIKOR BIOPHARMA LIMITED is a private limited company registered in the United Kingdom, based in 80 Cheapside, London EC2V 6EE. Companies House classifies its business as Other research and experimental development on natural sciences and engineering. It has been on the register for 25 years 6 months.
The register currently records it as active. Its 2025 accounts report net assets of £9.20M and 0 employees. Its accounts are past the filing deadline shown on the registry record.
ANTIKOR BIOPHARMA LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does ANTIKOR BIOPHARMA LIMITED do?
Companies House records ANTIKOR BIOPHARMA LIMITED under one registered business activity: Other research and experimental development on natural sciences and engineering (72.19 - SIC 2007).
Is ANTIKOR BIOPHARMA LIMITED still active?
ANTIKOR BIOPHARMA LIMITED is recorded as active on the Companies House register, and has been on it since 01/03/2001.
What are ANTIKOR BIOPHARMA LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £9.20M, total assets of £430.75K, cash in bank of £108.89K and total liabilities of £4.46M.
When did ANTIKOR BIOPHARMA LIMITED last file with Companies House?
The most recent document on the record is dated 15/07/2026: Previous accounting period shortened from 2026-07-31 to 2025-12-31, 2 months ago.
When are ANTIKOR BIOPHARMA LIMITED's next filings due?
On the current registry record, accounts are due by 30/04/2026, which has passed.
Who runs ANTIKOR BIOPHARMA LIMITED?
Companies House lists 18 officers (4 currently in post) and 5 people with significant control (3 current).